Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
09/26/2002 | US20020137201 Detection of transmembrane potentials by optical methods |
09/26/2002 | US20020134984 Transition metal complex and light-emitting device |
09/26/2002 | DE10113976A1 Production of (hetero)aromatic nitriles, e.g. for pharmaceutical synthesis, involves reacting aryl halide with cyanide in presence of palladium compound, chelating di- or amino-phosphane ligand and chelating diamine |
09/26/2002 | DE10113402A1 New N,N'-bis-(Aminocarbonyl)-hydrazine derivatives are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, apoplexy, restenosis or tumors |
09/26/2002 | DE10112771A1 New 3-acylamino-3-phenyl-propionic acid derivatives, are integrin inhibitors useful e.g. for treating thrombosis, cardiac infarction, angina pectoris, tumor diseases, inflammation, osteoporosis or infections |
09/26/2002 | DE10112068A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site |
09/26/2002 | DE10100928A1 Kuppler/Entwickler- und Kuppler/Kuppler-Hybridfarbstoffe und -hybridfarbstoffvorprodukte Coupler / developer and coupler / coupler hybrid dyes and -hybridfarbstoffvorprodukte |
09/26/2002 | CA2445754A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
09/26/2002 | CA2441427A1 Biurethane derivatives |
09/26/2002 | CA2440482A1 Tryptase-inhibitors |
09/26/2002 | CA2435847A1 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
09/26/2002 | CA2434030A1 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
09/25/2002 | EP1243581A1 Pyridinium compounds useful for the treatment of AGE-related diseases |
09/25/2002 | EP1243579A1 Process for the production of pyridine derivatives |
09/25/2002 | EP1242399A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
09/25/2002 | EP1242397A1 Trans olefinic glucokinase activators |
09/25/2002 | EP1242390A1 Method for production of 1,3-disubstituted 2-nitroguanidines |
09/25/2002 | EP1242380A1 Improved process for preparing carbamoyl pyridinium compounds |
09/25/2002 | EP1242379A1 Curcumin analogues for treating cancer |
09/25/2002 | EP1242366A1 Salicylamides as serine protease and factor xa inhibitors |
09/25/2002 | EP1242352A2 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
09/25/2002 | EP1242078A2 Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats |
09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
09/25/2002 | EP0835257B1 Intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds |
09/25/2002 | EP0746312B1 Guanylhydrazones for treating inflammatory conditions |
09/25/2002 | CN1371367A Phenethyl-5-bromopyridyl thiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
09/25/2002 | CN1371366A Benzamide formulation with histone deacetylase inhibitor activity |
09/25/2002 | CN1371364A Tetrahydropyridines as pesticides |
09/25/2002 | CN1371357A Aminobenzoic acid derivatives |
09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
09/25/2002 | CN1370770A Pyridine recovering process |
09/25/2002 | CN1091442C Method for preparing phenylpyridyl substituted urea |
09/24/2002 | US6455701 Such as 4-((4'-tert-butyl-3'-(4?-trifluoromethyl)phenoxy) phenylethynyl)benzoic acid; side effect reduction |
09/24/2002 | US6455660 Given annealed density, charpy impact, and dynamic storage modulus; made using a tridentate nitrogen-containing transition metal polymerization catalyst |
09/24/2002 | US6455581 Inhibitors of hiv protease. |
09/24/2002 | US6455554 Oxopyridinyl pharmaceutical compositions and methods for use |
09/24/2002 | US6455551 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
09/24/2002 | US6455550 N-alkanoylphenylalanine derivatives |
09/24/2002 | US6455545 Gastrointestinal disorders |
09/24/2002 | US6455528 Tumor necrosis factor antagonist and/or interleukin promoter; antiallergens, antiinflammatory agents; autoimmune disease treatment |
09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
09/20/2002 | WO2001070692A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
09/20/2002 | CA2403807A1 Heterocyclic acylsulfimides,processes for their preparation,compositionscomprising them and their use as pesticides |
09/19/2002 | WO2002072869A2 Novel agents for replacement of nad+/nadh system in enzymatic ractions |
09/19/2002 | WO2002072707A1 Pyridone dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles |
09/19/2002 | WO2002072654A2 Polymers and oligomers, their synthesis, and electronic devices incorporating same |
09/19/2002 | WO2002072564A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
09/19/2002 | WO2002072559A1 Process to intermediates for biologically active compounds |
09/19/2002 | WO2002072553A1 Antiproliferative agents |
09/19/2002 | WO2002072544A2 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
09/19/2002 | WO2002072540A2 Improved methods of ortho alkylation |
09/19/2002 | WO2002072532A1 7, 9-substituted tetracycline compounds |
09/19/2002 | WO2002072518A2 Method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds |
09/19/2002 | WO2002072511A1 'convenient and efficient suzuki-miyaura cross-coupling catalyzed by a palladium/diazabutadiene system' |
09/19/2002 | WO2002072092A1 Method for increasing leptin levels using nicotinic acid compounds |
09/19/2002 | WO2002072091A1 Anticancer drug-tolerance inhibitors |
09/19/2002 | WO2002072084A2 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
09/19/2002 | WO2002029021A3 Biotechnological method for preparing carboxylic acids with a hydroxy-nitrogen heterocycle |
09/19/2002 | WO2002024194A9 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
09/19/2002 | WO2002014311A3 Urea compounds and methods of uses |
09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
09/19/2002 | US20020133023 Antitumor agents, osteoporosis |
09/19/2002 | US20020133015 4-pyridinyl-N-acyl-L-phenylalanines |
09/19/2002 | US20020133013 Reacting halobenzoic acid with 2,2,2-trifluoroethanol; thenhaloacetonitrile |
09/19/2002 | US20020133005 Heterocyclic compounds and medical use thereof |
09/19/2002 | US20020132888 Alkylthio-and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber |
09/19/2002 | US20020132853 Diaryl piperazines and related compounds useful in the treatment of a chronic and acute pain conditions, itch and urinary incontinence. |
09/19/2002 | US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
09/19/2002 | US20020132830 Use of beta 2 bronchodilator drugs |
09/19/2002 | US20020132816 Estrogen agonists/antagonists for preventing breast cancer |
09/19/2002 | US20020132807 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
09/19/2002 | US20020132794 Compounds and methods for inhibition of HIV and related viruses |
09/19/2002 | DE10113027A1 3-Diaminophenyl-acrylamide derivatives or their physiologically acceptable, water-soluble salts, used as developers in combination with couplers in oxidative dye formulations, especially for dyeing hair are new |
09/19/2002 | DE10110754A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
09/19/2002 | DE10110438A1 Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and their use |
09/19/2002 | DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway |
09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
09/19/2002 | CA2441745A1 Polymers and oligomers, their synthesis, and electronic devices incorporating same |
09/19/2002 | CA2437755A1 Improved methods of ortho alkylation |
09/19/2002 | CA2434837A1 Pyridone dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles |
09/18/2002 | EP1241170A2 Pyrazolopyrimidine derivatives |
09/18/2002 | EP1240906A1 Preventives or remedies for arrhythmia |
09/18/2002 | EP1240162A2 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
09/18/2002 | EP1240154A1 Serine protease inhibitors |
09/18/2002 | EP1240147A1 Potassium channel inhibitors |
09/18/2002 | EP1240145A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
09/18/2002 | EP1240144A2 Compound having effect of promoting neuron differentiation |
09/18/2002 | EP1240133A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
09/18/2002 | EP1036059B1 Adamantane derivatives |
09/18/2002 | EP0950056B1 N-(pyridinylamino)isoindolines and related compounds |
09/18/2002 | EP0888322B1 Electrophilic ketones for the treatment of herpesvirus infections |
09/18/2002 | EP0865424B1 Pesticides |
09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
09/18/2002 | EP0700388B1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors |
09/18/2002 | CN1370168A Novel spiro compounds |